Circulating tumor cells in metastatic breast cancer: Timing of blood extraction for analysis

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 4185-4187

  Martín, Miguel ^a   García Sáenz, José Ángel ^a   De Las Casas, Maria Luisa Maestro ^a   Vidaurreta, Marta ^a   Puente, Javier ^a   Veganzones, Silvia ^a   Rodríguez Lajusticia, Laura ^a   De La Orden, Virginia ^a   Oliva, Belén ^a   De La Torre, Julio César ^a   López Tarruella, Sara ^a   Casado, Antonio ^a   Sastre, Javier ^a   Díaz Rubio, Eduardo ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Breast cancer; Circulating tumor cells

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CELL CYCLE; CIRCADIAN RHYTHM; COHORT ANALYSIS; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE; TIME; TUMOR CELL;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PILOT PROJECTS;

EID: 71949121605     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Pierga JY, Bonneton C, Vincent-Salomon A et al: Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral and bone marrow breast cancer patients. Clin Cancer Res 10: 1392-1400, 2004. (Pubitemid 38365234)
2. Cristofanilli M, Budd GT, Ellis M et al: Circulating tumor cells predict progression-free survival and overall survival in metastatic breast cancer. N Engl J Med 351: 781-791, 2004. (Pubitemid 39095313)
3. Budd GT, Cristofanilli M, Ellis MJ et al: Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res 12: 6403-6409, 2006. (Pubitemid 44799711)
4. Cristofanilli M: Circulating tumor cells, disease progression and survival in metastatic breast cancer. Semin Oncol 33(Suppl 9): S9-S14, 2006.
5. Sephton S and Spiegel S: Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav Immun 17: 321-328, 2003.
6. García-Saenz JA, Martin M, Maestro M et al: Circulating tumoral cells lack circadian rhythm in hospitalized metastatic breast cancer patients. Clin Transl Oncol 8: 826-829, 2006.
7. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F and Okamura H: Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255-259, 2003. (Pubitemid 37248750)
8. Pachmann K: Circulating tumor cells in breast cancer: fiction or reality (letter, in reply). J Clin Oncol 26: 3657-3658, 2008.
9. Christofanilli M, Reuben J and Uhr J: Circulating tumor cells in breast cancer: fiction or reality (letter ). J Clin Oncol 26: 3656-3657, 2008.